➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Merck
Medtronic
Colorcon
AstraZeneca

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Children's Cetirizine Hydrochloride Allergy patents expire, and what generic alternatives are available?

Children's Cetirizine Hydrochloride Allergy is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Athem, Aurobindo Pharma, Cypress Pharm, Hetero Labs Ltd Iii, Lannett Co Inc, Perrigo R And D, Pharm Assoc, Quagen, Ranbaxy Labs Ltd, Taro, Torrent, Tris Pharma Inc, Jubilant Generics, Novel Labs Inc, Sandoz, and Sun Pharm. and is included in twenty NDAs.

The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Children's Cetirizine Hydrochloride Allergy

A generic version of CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.

  Start Trial

Summary for CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
Drug patent expirations by year for CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
Recent Clinical Trials for CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hamad Medical CorporationPhase 1
Stefania La Grutta, MDPhase 4
Medical Universtity of LodzPhase 4

See all CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY clinical trials

US Patents and Regulatory Information for CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride SYRUP;ORAL 090378-002 May 9, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Jubilant Generics CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 091116-002 Feb 19, 2015 OTC No No   Start Trial   Start Trial   Start Trial
Sun Pharm CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 090142-002 Aug 30, 2011 OTC No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride SYRUP;ORAL 091130-001 Apr 22, 2011 OTC No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride SYRUP;ORAL 090750-002 Feb 2, 2010 OTC No No   Start Trial   Start Trial   Start Trial
Ranbaxy Labs Ltd CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride SYRUP;ORAL 090183-002 Apr 24, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Novel Labs Inc CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 206793-002 Mar 8, 2016 OTC No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Boehringer Ingelheim
Dow
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.